Related Experiment Video
Updated: Jul 14, 2025

08:38
A Strategy for the Study of IL-9-Producing Lymphoid Cells in the Nippostrongylus brasiliensis Infection Model
Published on: March 3, 2023
1.4K
Unexpected Clinical Lessons Learned From IL-4 and IL-13 Blockade
Journal of Drugs in Dermatology : JDD
|October 6, 2023
Abstract:
In 2017, dupilumab became the first FDA approved systemic therapy for atopic dermatitis. Since its approval, extensive clinical experience and continued research have revealed a number of unexpected effects that are highly clinically relevant. We will review these clinical effects and the supporting evidence.J Drugs Dermatol. 2023;22(10):1007-1008 doi:10.36849/JDD.7249.

